[Prognostic evaluation of the absolute lymphopenia during prednisolone therapy of chronic pulmonary sarcoidosis (author's transl)].
From a controlled prednisolone therapy trial 130 patients with chronic pulmonary sarcoidosis who had already finished their drug-therapy were evaluated. The relapse rate was 28.5% within the following two years. It is obvious, that the long-time prognosis of cases with very low absolute numbers of lymphocytes in the peripheral blood (1000 and less/mul) is significantly poorer than in all other cases.
D002908:Chronic Disease; D006801:Humans; D008171:Lung Diseases / Q000150:complications / Q000188:drug therapy*; D008231:Lymphopenia / Q000139:chemically induced / Q000175:diagnosis*; D011239:Prednisolone / Q000009:adverse effects* / Q000627:therapeutic use; D011379:Prognosis; D012008:Recurrence; D012507:Sarcoidosis / Q000150:complications / Q000188:drug therapy*
D011239:Prednisolone
Zur prognostischen Bedeutung der absoluten Lymphopenie unter der Prednisolontherapie der chronischen Lungensarkoidose